or Try an Advanced Search...

    Treatment Of Migraine Stocks List

    Symbol Grade Name % Change
    ASRT D Assertio Therapeutics, Inc. 7.85
    ABBV D AbbVie Inc. -0.69
    AMRX A Amneal Pharmaceuticals, Inc. 1.64
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Migraine Pharmaceutical Acute Pain Adalimumab Advanced Prostate Cancer Amino Acids Analgesics Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chemical Compounds Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Diabetic Peripheral Neuropathy Drug Products Drugs

    Related ETFs - A few ETFs which own one or more of the above listed Treatment Of Migraine stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 9.87
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 9.04
    GRID B First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 8.3
    MEDX F Horizon Kinetics Medical ETF 7.88
    View all Treatment Of Migraine ETFs...
    Compare ETFs
    Compare BOTZ to GRID Compare HDLB to BOTZ Compare MEDI to GRID

        Treatment Of Migraine Stocks Recent News

        Date Stock Title
        May 2 ABBV The top pharmaceutical companies by R&D expenditure
        May 1 ABBV BeiGene, AbbVie patent spat to get trial from USPTO appeals board
        May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
        Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
        Apr 30 ABBV AbbVie (ABBV) Could Be a Great Choice
        Apr 30 ABBV AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
        Apr 30 ABBV Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
        Apr 29 ABBV AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
        Apr 29 ABBV AbbVie: The Inevitable Is Happening
        Apr 29 ABBV Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)
        Apr 29 ABBV Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 28 ABBV Dividend Stock Portfolio For Income: Top 15 Stocks
        Apr 28 ABBV AbbVie First Quarter 2024 Earnings: Beats Expectations
        Apr 28 ABBV Better Dividend Stock: AbbVie or Johnson & Johnson?
        Apr 27 ABBV 3 Dividend Stocks to Buy and Hold for the Next Decade
        Apr 27 ABBV AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
        Apr 27 ABBV Q1 2024 AbbVie Inc Earnings Call
        Apr 26 ABBV Abbvie stock falls amid growing biosimilar competition
        Apr 26 ABBV Why AbbVie Stock Stumbled Today Despite the Earnings Beat
        Apr 26 ABBV AbbVie (ABBV) Q1 2024 Earnings Call Transcript
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Migraine Pharmaceutical Acute Pain Adalimumab Advanced Prostate Cancer Amino Acids Analgesics Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Chemical Compounds Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Diabetic Peripheral Neuropathy Drug Products Drugs
        Treatment Of Migraine

        Treatment of migraine typically involves medications to reduce the intensity of the headache and prevent future attacks. Medications used to treat migraine include triptans, nonsteroidal anti-inflammatory drugs (NSAIDs), antiemetics, and anticonvulsants. Other treatments may include lifestyle modifications, such as avoiding triggers, stress management, and relaxation techniques. In some cases, preventive medications may be prescribed to reduce the frequency and severity of migraine attacks.

        Browse All Tags